Received Jun 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
severe pneumonia; immune system was damaged; This serious case was reported by a consumer via interactive digital media and described the occurrence of pneumonia in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, 1 day after receiving RSV vaccine, the patient experienced pneumonia (Verbatim: severe pneumonia) (serious criteria GSK medically significant) and immune system disorder (Verbatim: immune system was damaged). The outcome of the pneumonia and immune system disorder were not reported. It was unknown if the reporter considered the pneumonia to be related to RSV vaccine. The reporter considered the immune system disorder to be related to RSV vaccine. The company considered the pneumonia to be unrelated to RSV vaccine. The company considered the immune system disorder to be related to RSV vaccine. Additional Information: GSK Receipt Date: 05-JUN-2025 This case was reported by a patient via interactive digital media. Patient had received the shot, and the next day, he/she began a five-month battle with severe pneumonia. Patient believe it had damaged his/her immune system, never again.; Sender's Comments: Pneumonia is an unlisted event which is considered unrelated to GSK RSV vaccine.